The Model Fentanyl/Xylazine Test Strip and Other Drug Checking Equipment Act provides a guide for states to introduce legislation to authorize the use and possession of drug checking equipment.
The Model Fentanyl/Xylazine Test Strip and Other Drug Checking Equipment Act provides a guide for states to introduce legislation to authorize the use and possession of drug checking equipment.
Because no safe supply of most illicitly used drugs is available, helping people determine what is in the drugs they obtain can be an impactful harm reduction intervention. The easiest and most inexpensive way to accomplish this is often through use of fentanyl test strips and xylazine test strips. This resource outlines the legality of drug checking equipment in 50 states and the District of Columbia, as of 2024.
Syringe services programs (SSP) are harm reduction programs that provide a wide range of services including the provision of new, unused hypodermic needles and syringes and other injection drug use supplies. In this summary, readers will find information with respect to SSPs for each state, including citations to applicable statutes and/or regulations, whether the state allows SSPs by statute, whether there are any municipal or county ordinances or regulations in place within the state, program components, miscellaneous provisions, and information on any pending legislation (as of August, 2023).
This four-part webinar series is designed to provide state and local decision makers, government agencies, public health practitioners, and community members with insight into tools and resources for selecting, adopting, and implementing policies to reduce overdose and other drug-related harm.
This four-part webinar series is designed to provide state and local decision makers, government agencies, public health practitioners, and community members with insight into tools and resources for selecting, adopting, and implementing policies to reduce overdose and other drug-related harm.
This four-part webinar series is designed to provide state and local decision makers, government agencies, public health practitioners, and community members with insight into tools and resources for selecting, adopting, and implementing policies to reduce overdose and other drug-related harm.
This four-part webinar series is designed to provide state and local decision makers, government agencies, public health practitioners, and community members with insight into tools and resources for selecting, adopting, and implementing policies to reduce overdose and other drug-related harm.
States have enacted multiple types of laws, with a variety of constituent provisions, in response to the opioid epidemic, often simultaneously. This temporal proximity and variation in state-to-state operationalization has resulted in significant challenges for empirical research on their effects. Thus, expert consensus can be helpful to classify laws and their provisions by their degree of helpfulness and impact. Overall, experts rated laws and provisions that facilitated harm reduction efforts and access to MOUD as most helpful. Laws and provisions rated as most harmful criminalized substance use and placed restrictions on access to MOUD. These ratings provide a foundation for evaluating the overall overdose policy environment for each state.
While the health impacts of mass incarceration have been explored, less attention has been paid to how the “war on drugs” in the United States exacerbates many of the factors that negatively impact health and wellbeing. This paper examines the ways that “drug war logic” has become embedded in key SDOH and systems. We argue that, because the drug war has become embedded in these systems, medical practitioners can play a significant role in promoting individual and community health by reducing the impact of criminalisation upon healthcare service provision and by becoming engaged in policy reform efforts.